The Effects of Anti-TGF-β1 on Epithelial–Mesenchymal Transition in the Pathogenesis of Adenomyosis
- 6 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Reproductive Sciences
- Vol. 27 (9), 1698-1706
- https://doi.org/10.1007/s43032-020-00139-0
Abstract
Adenomyosis is defined as the presence of endometrial glands and stroma in the myometrium. The mechanisms associated with the pathogenesis of adenomyosis remain unclear. Epithelial–mesenchymal transition (EMT) is characterized by losing cell polarity and cell–cell adhesion together with gaining migratory and invasive properties of stromal cells to become mesenchymal stem cells. Transforming growth factor-β1 (TGF-β1), an anti-inflammatory cytokine secreted by multiple cell types, plays a crucial role in embryogenesis and tissue homeostasis. The induction of EMT and ultimate fibrosis by TGF-β1 is suggested to play a critical role in the pathogenesis of adenomyosis. Thus, this study aims to demonstrate the occurrence of EMT in and the effects of anti-TGF-β1 on the pathogenesis of adenomyosis. ICR mice were fed with 1 μg/g body weight of tamoxifen (TAM) by in the first 4 postnatal days (PNDs). Subsequently, the right and left uterine horns were correspondingly injected with or without 10 μg of anti-TGF-β1 neutralizing antibody on PND42 followed by sacrifice on PND64. E-cadherin, vimentin, and α-smooth muscle actin (α-SMA) expression in the uteri was evaluated by qRT-PCR, Western blot, and immunohistochemistry. Clusters of endometrial glands and increased numbers of vimentin-positive stromal cells in the disrupted α-SMA-positive myometrium were observed in the uteri from TAM-treated mice. Numbers of stromal cells in the myometrium and the disrupted myometrial continuity were reduced by anti-TGF-β1. Moreover, uterine expression of E-cadherin and vimentin/α-SMA was increased and decreased by anti-TGF-β1 treatment, respectively. Anti-TGF-β1 successfully inhibits EMT and the development of adenomyosis in mouse uteri.Keywords
Funding Information
- E-Da Hospital Grants (EDAHP 106053,EDAHP107035,EDAHP108014, EDAHP10701)
This publication has 58 references indexed in Scilit:
- Role of medical therapy in the management of uterine adenomyosisFertility and Sterility, 2018
- The Role of Stem Cells in the Etiology and Pathophysiology of EndometriosisSeminars in Reproductive Medicine, 2015
- Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI studyArchiv für Gynäkologie, 2014
- Uterine peristalsis-induced stresses within the uterine wall may sprout adenomyosisBiomechanics and Modeling in Mechanobiology, 2014
- Preoperative and Postoperative Clinical and Transvaginal Ultrasound Findings of Adenomyosis in Patients With Deep Infiltrating EndometriosisReproductive Sciences, 2014
- Clinical profiles of 710 premenopausal women with adenomyosis who underwent hysterectomyJournal of Obstetrics and Gynaecology Research, 2013
- The pathophysiology of uterine adenomyosis: an updateFertility and Sterility, 2012
- Pathology and physiopathology of adenomyosisBest Practice & Research Clinical Obstetrics & Gynaecology, 2006
- Medical and surgical management of adenomyosisBest Practice & Research Clinical Obstetrics & Gynaecology, 2006
- Adenomyosis—A Result of Disordered Stromal DifferentiationThe American Journal of Pathology, 2001